Hepatocellular Carcinoma Rupture Following Transarterial Chemoembolization
نویسندگان
چکیده
منابع مشابه
Transarterial chemoembolization for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is common cancer in the world. Hepatitis B/C or alcoholic cirrhosis is usually underlying condition. Surgical resection is curative treatment for small HCC, however most patients usually present when advanced or inoperable disease. Transarterial chemoembolization (TACE) is most common alternative treatment for early and advanced HCC. Curative treatment is possible...
متن کاملHemorrhage Following Drug-Eluting Bead Transarterial Chemoembolization of Hepatocellular Carcinoma
We report the case of a 78-year-old woman with hepatocellular carcinoma who underwent drug-eluting bead transarterial chemoembolization (DEB-TACE). On the first routine follow-up CT six-weeks post procedure, the patient was found to have residual enhancing tumor and active intra-tumoral hemorrhage (Fig 1A). Follow-up laboratory values demonstrated a decrease in hemoglobin. Subsequent catheter a...
متن کاملLocoregional Transarterial Therapies for Hepatocellular Carcinoma: Transarterial Chemoembolization and Radioembolization
Background: Hepatocellular carcinoma (HCC) is the sixth most common cancer in the world and the third most common cause of cancer-related mortality. Despite the widespread implementation of surveillance programs, more than half of the patients with HCC are diagnosed at late stages, when curative treatments (resection or liver transplantation) cannot be applied. For patients presenting with unre...
متن کاملTransarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
PURPOSE In hepatocellular carcinoma patients with large or multinodal tumors, where curative treatment options are not feasible, transarterial therapies play a major role. Transarterial chemoembolization (TACE) with drug-eluting beads (DEB-TACE) is a promising new approach due to higher intratumoral and lower systemic concentration of the chemotherapeutic agent compared to conventional TACE (cT...
متن کاملTransarterial chemoembolization for the treatment of hepatocellular carcinoma: a review
According to the current European Association for the Study of Liver guidelines, transarterial chemoembolization (TACE) is the recommended first-line therapy for patients with intermediate-stage (Barcelona Clinic Liver Cancer-B class) hepatocellular carcinoma (HCC). The efficacy of this therapy is supported by robust evidence; however, there is still a lack of standardization in treatment metho...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Seminars in Interventional Radiology
سال: 2015
ISSN: 0739-9529,1098-8963
DOI: 10.1055/s-0034-1396964